Related references
Note: Only part of the references are listed.T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma
Suvi-Katri Leivonen et al.
HAEMATOLOGICA (2019)
Modulation of immune checkpoint molecule expression in mantle cell lymphoma
Bonnie K. Harrington et al.
LEUKEMIA & LYMPHOMA (2019)
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
Daisuke Ennishi et al.
CANCER DISCOVERY (2019)
Mass Cytometry Analysis Reveals that Specific Intratumoral CD4+ T Cell Subsets Correlate with Patient Survival in Follicular Lymphoma
Zhi-Zhang Yang et al.
CELL REPORTS (2019)
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas
Marien Pascual et al.
BLOOD (2019)
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
Philippe Armand et al.
BLOOD (2019)
CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages
Antonin Papin et al.
LEUKEMIA (2019)
Novel risk stratification of de novo diffuse large B cell lymphoma based on tumour-infiltrating T lymphocytes evaluated by flow cytometry
Zihang Chen et al.
ANNALS OF HEMATOLOGY (2019)
Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study
Stephen M. Ansell et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program
Ling Li et al.
MODERN PATHOLOGY (2019)
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
Anas Younes et al.
LANCET HAEMATOLOGY (2019)
Novel agents for relapsed and refractory follicular lymphoma
Chan Yoon Cheah et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2018)
Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironment
Fathima Zumla Cader et al.
BLOOD (2018)
Critical influences on the pathogenesis of follicular lymphoma
Ralf Kueppers et al.
BLOOD (2018)
CD4+T cell-mediated cytotoxicity is associated with MHC class II expression on malignant CD19+B cells in diffuse large B cell lymphoma
Yong Zhou et al.
EXPERIMENTAL CELL RESEARCH (2018)
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
Margaretha G. M. Roemer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
Philippe Armand et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Ibrutinib induces rapid down-regulation of inflammatory markers and altered transcription of chronic lymphocytic leukaemia-related genes in blood and lymph nodes
Marzia Palma et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth
Lorena Fontan et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
Peter Hollander et al.
PLOS ONE (2018)
Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue
S. Ciavarella et al.
ANNALS OF ONCOLOGY (2018)
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma
Ranjana Advani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs
Jan Devan et al.
SEMINARS IN ONCOLOGY (2018)
Profiling Immune Escape in Hodgkin's and Diffuse large B-Cell Lymphomas Using the Transcriptome and Immunostaining
Sarah Pericart et al.
CANCERS (2018)
Glutaminolysis Mediated by MALT1 Protease Activity Facilitates PD-L1 Expression on ABC-DLBCL Cells and Contributes to Their Immune Evasion
Xichun Xia et al.
FRONTIERS IN ONCOLOGY (2018)
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma
Alex F. Herrera et al.
BLOOD (2018)
Phase 1/2 Study of Brentuximab Vedotin in Combination with Nivolumab in Patients with Relapsed or Refractory Classic Hodgkin Lymphoma: Part 3 (Concurrent Dosing) Results and Updated Progression-Free Survival Results from Parts 1 and 2 (Staggered Dosing)
Ranjana H. Advani et al.
BLOOD (2018)
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Marzia Palma et al.
HAEMATOLOGICA (2017)
CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas
Yanwen Jiang et al.
CANCER DISCOVERY (2017)
Nurse-like cells promote CLL survival through LFA-3/CD2 interactions
Frederic Boissard et al.
ONCOTARGET (2017)
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Marzia Palma et al.
HAEMATOLOGICA (2017)
Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma
Juhyeon Jeong et al.
HUMAN PATHOLOGY (2017)
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
Robert Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood
T. M. Herndon et al.
LEUKEMIA (2017)
Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth
Hind Hashwah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors
Alexander W. MacFarlane et al.
ONCOIMMUNOLOGY (2017)
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma
Christopher D. Carey et al.
BLOOD (2017)
High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome
Peter Hollander et al.
BLOOD ADVANCES (2017)
Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management
Julie M. Vose
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma
Pier Luigi Zinzani et al.
BLOOD (2017)
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL
Wei Ding et al.
BLOOD (2017)
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma
Lakshmi Nayak et al.
BLOOD (2017)
IL-4/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma
Shubham Pandey et al.
BLOOD (2017)
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma
Reid W. Merryman et al.
BLOOD (2017)
HLA-G and MHC Class II Protein Expression in Diffuse Large B-Cell Lymphoma
Dorota Jesionek-Kupnicka et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2016)
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy et al.
BLOOD (2016)
Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas
Dohee Kwon et al.
HISTOPATHOLOGY (2016)
FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
P. J. Brown et al.
LEUKEMIA (2016)
BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia
S-S Chen et al.
LEUKEMIA (2016)
CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates
Elena M. Hartmann et al.
LEUKEMIA & LYMPHOMA (2016)
Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma
Young Wha Koh et al.
TUMOR BIOLOGY (2016)
The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome
Jacob R. Bledsoe et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma
Thomas S. Y. Chan et al.
ANNALS OF HEMATOLOGY (2016)
IL-4 enhances expression and function of surface IgM in CLL cells
Maria M. Aguilar-Hernandez et al.
BLOOD (2016)
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas
Konstantinos Georgiou et al.
BLOOD (2016)
Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy
Bruce D. Cheson et al.
BLOOD (2016)
Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma
Baoping Guo et al.
BMC MEDICINE (2016)
Negative prognostic impact of low absolute CD4+ T cell counts in peripheral blood in mantle cell lymphoma
Xin-Yu Zhang et al.
CANCER SCIENCE (2016)
Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
Avery Polk et al.
CLINICAL CANCER RESEARCH (2016)
Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas
Thomas Menter et al.
HUMAN PATHOLOGY (2016)
Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure
Philippe Armand et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
Alexander M. Lesokhin et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Margaretha G. M. Roemer et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Nurse-like cells impact on disease progression in chronic lymphocytic leukemia
F. Boissard et al.
BLOOD CANCER JOURNAL (2016)
PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications
Wei Xing et al.
ONCOTARGET (2016)
Classical Hodgkin Lymphoma with Reduced β2M/MHC Class I Expression Is Associated with Inferior Outcome Independent of 9p24.1 Status
Margaretha G. M. Roemer et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Novel Drugs in Follicular Lymphoma
Antonella Anastasia et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2016)
Intratumoral FOXP3+ Regulatory T Cells in Diffuse Large B-Cell Lymphoma
Marwa M. Serag El-Dien et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2016)
PD-L1 Status in Refractory Lymphomas
Semir Vranic et al.
PLOS ONE (2016)
DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma
Rada Amin et al.
BLOOD (2015)
Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
Junichi Kiyasu et al.
BLOOD (2015)
Tumor-associated macrophages in diffuse large B-cell lymphoma
Robert Kridel et al.
HAEMATOLOGICA (2015)
Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart
Chen Chang et al.
HISTOPATHOLOGY (2015)
Nurse like cells: chronic lymphocytic leukemia associated macrophages
Frederic Boissard et al.
LEUKEMIA & LYMPHOMA (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation
Michael R. Green et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK
Idit Sagiv-Barfi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The Histological Classification of Diffuse Large B-cell Lymphomas
Yi Xie et al.
SEMINARS IN HEMATOLOGY (2015)
Molecular Pathogenesis of MALT Lymphoma
Katharina Troppan et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2015)
IL-10 induces the development of immunosuppressive CD14+ HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma
B. Xiu et al.
BLOOD CANCER JOURNAL (2015)
PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival
Z-Z Yang et al.
BLOOD CANCER JOURNAL (2015)
Genomic Alterations in CIITA Are Frequent in Primary Mediastinal Large B Cell Lymphoma and Are Associated with Diminished MHC Class II Expression
Anja Mottok et al.
CELL REPORTS (2015)
Tumor-associated macrophages in diffuse large B-cell lymphoma
Robert Kridel et al.
HAEMATOLOGICA (2015)
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study
Colm Keane et al.
LANCET HAEMATOLOGY (2015)
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells
Jonathan Reichel et al.
BLOOD (2015)
Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi- automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP
Rita Coutinho et al.
HAEMATOLOGICA (2015)
Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study
H. R. Junlen et al.
LEUKEMIA (2015)
Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease
Lan V. Pham et al.
LEUKEMIA & LYMPHOMA (2015)
Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia
Li Jia et al.
BLOOD (2014)
Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma
David D. W. Twa et al.
BLOOD (2014)
Differences in incidence and trends of haematological malignancies in Japan and the United States
Dai Chihara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Molecular Pathways: Targeting the Microenvironment in Chronic Lymphocytic Leukemia-Focus on the B-Cell Receptor
Elisa ten Hacken et al.
CLINICAL CANCER RESEARCH (2014)
T-Cell Levels Are Prognostic in Mantle Cell Lymphoma
Lina Nygren et al.
CLINICAL CANCER RESEARCH (2014)
PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL)
Anna Sophie Berghoff et al.
CLINICAL NEUROPATHOLOGY (2014)
Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages
Young Wha Koh et al.
HEMATOLOGICAL ONCOLOGY (2014)
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
D. Rossille et al.
LEUKEMIA (2014)
Expansion of NK Cells and Reduction of NKG2D Expression in Chronic Lymphocytic Leukemia. Correlation with Progressive Disease
Leticia Huergo-Zapico et al.
PLOS ONE (2014)
The yin and the yang of follicular lymphoma cell niches: Role of microenvironment heterogeneity and plasticity
Patricia Ame-Thomas et al.
SEMINARS IN CANCER BIOLOGY (2014)
Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma
Matthew J. Ahearne et al.
VIRCHOWS ARCHIV (2014)
The tumour microenvironment in B cell lymphomas
David W. Scott et al.
NATURE REVIEWS CANCER (2014)
CD4+Tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy
Colm Keane et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production
John C. Riches et al.
BLOOD (2013)
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells
Paul Greaves et al.
BLOOD (2013)
Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide
Alan G. Ramsay et al.
BLOOD (2013)
Lenalidomide Inhibits Lymphangiogenesis in Preclinical Models of Mantle Cell Lymphoma
Kai Song et al.
CANCER RESEARCH (2013)
PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
Benjamin J. Chen et al.
CLINICAL CANCER RESEARCH (2013)
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
Davide Brusa et al.
HAEMATOLOGICA (2013)
Immune evasion of mantle cell lymphoma: expression of B7-H1 leads to inhibited T-cell response to and killing of tumor cells
Lijuan Wang et al.
HAEMATOLOGICA (2013)
Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma
Kelly A. Cycon et al.
IMMUNOLOGY (2013)
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Philippe Armand et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Nonstereotyped Lymphoma B Cell Receptors Recognize Vimentin as a Shared Autoantigen
Soung-Chul Cha et al.
JOURNAL OF IMMUNOLOGY (2013)
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Silvia Bea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Low GILT expression is associated with poor patient survival in diffuse large B-cell lymphoma
Hannah Phipps-Yonas et al.
FRONTIERS IN IMMUNOLOGY (2013)
Germinal Centers
Gabriel D. Victora et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma
Sarah T. Wilkinson et al.
BLOOD (2012)
Self-antigen recognition by follicular lymphoma B-cell receptors
Kacey L. Sachen et al.
BLOOD (2012)
Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer
Alan G. Ramsay et al.
BLOOD (2012)
Expansion of a CD8+PD-1+ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression
Claudia Nunes et al.
CLINICAL CANCER RESEARCH (2012)
4-1BB ligand modulates direct and Rituximab-induced NK-cell reactivity in chronic lymphocytic leukemia
Corina Buechele et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways
Daniel J. Medina et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Molecular pathogenesis of mantle cell lymphoma
Pedro Jares et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling
G. Epron et al.
LEUKEMIA (2012)
Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia
M. Sivina et al.
LEUKEMIA (2012)
Entourage: the immune microenvironment following follicular lymphoma
B. E. Wahlin et al.
BLOOD CANCER JOURNAL (2012)
Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities
Nicholas Chiorazzi et al.
BLOOD (2011)
Immunosuppressive CD14+HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma
Yi Lin et al.
BLOOD (2011)
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia
Mariela Sivina et al.
BLOOD (2011)
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy
Mark P. Chao et al.
BLOOD (2011)
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma
Fabio Munari et al.
BLOOD (2011)
Nurse-like cells show deregulated expression of genes involved in immunocompetence
Nupur Bhattacharya et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
Madhavi Challa-Malladi et al.
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab
Bjorn Engelbrekt Wahlin et al.
CLINICAL CANCER RESEARCH (2011)
Programmed Death Ligand 1 Is Expressed by Non-Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells
David J. Andorsky et al.
CLINICAL CANCER RESEARCH (2011)
Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma
Bill G. Richendollar et al.
HUMAN PATHOLOGY (2011)
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
Christian Steidl et al.
NATURE (2011)
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
Michael R. Green et al.
BLOOD (2010)
Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38+CD49d+chronic lymphocytic leukaemia cells
Antonella Zucchetto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Mark P. Chao et al.
CELL (2010)
A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1-Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages
Bjorn Engelbrekt Wahlin et al.
CLINICAL CANCER RESEARCH (2010)
Diagnostic and prognostic utility of PD-1 in B cell lymphomas
S. Muenst et al.
DISEASE MARKERS (2010)
Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH-B cell axis
C. Pangault et al.
LEUKEMIA (2010)
B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis
V. J. Craig et al.
LEUKEMIA (2010)
CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Karin Rydstrom et al.
LEUKEMIA & LYMPHOMA (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins
Vania Coelho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation
Jan A. Burger et al.
BLOOD (2009)
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
Asad Bashey et al.
BLOOD (2009)
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
Maite P. Quiroga et al.
BLOOD (2009)
Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance
Antonina V. Kurtova et al.
BLOOD (2009)
Phase I Study of Ipilimumab, an Anti-CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma
Stephen M. Ansell et al.
CLINICAL CANCER RESEARCH (2009)
Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL)
Kell A. Cycon et al.
EXPERIMENTAL HEMATOLOGY (2009)
High Numbers of Tumor-Infiltrating Programmed Cell Death 1-Positive Regulatory Lymphocytes Are Associated With Improved Overall Survival in Follicular Lymphoma
Joaquim Carreras et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
CXCR4 Expression Functionally Discriminates Centroblasts versus Centrocytes within Human Germinal Center B Cells
Gersende Caron et al.
JOURNAL OF IMMUNOLOGY (2009)
Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas
Cecile Meier et al.
MODERN PATHOLOGY (2009)
Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy
M. Wang et al.
LEUKEMIA (2009)
Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade
Christian P. Pallasch et al.
LEUKEMIA RESEARCH (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment
Piers E. M. Patten et al.
BLOOD (2008)
PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
Ryo Yamamoto et al.
BLOOD (2008)
IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma
Katherine R. Calvo et al.
BLOOD (2008)
Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia
Shanique Palmer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions
Donatella Aldinucci et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug
Alan G. Ramsay et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G
G. Maki et al.
LEUKEMIA (2008)
Expression profiling reveals specific gene expression signatures in gastric MALT lymphomas
Minh Quang Huynh et al.
LEUKEMIA & LYMPHOMA (2008)
The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression
Todd W. Kelley et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Distribution patterns of dendritic cells and T cells in Diffuse large B-cell lymphomas correlate with prognoses
Kung-Chao Chang et al.
CLINICAL CANCER RESEARCH (2007)
Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia
Andrea Buerkle et al.
BLOOD (2007)
Hodgkin's Reed-Sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+ CD25+ Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells
Tsutomu Tanijiri et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
A pilot study of CTLA-4 blockade after cancer vaccine failure in patients with advanced malignancy
Deirdre O'Mahony et al.
CLINICAL CANCER RESEARCH (2007)
Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth:: role of stromal cells in follicular lymphoma pathogenesis
Patricia Ame-Thomas et al.
BLOOD (2007)
HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimen
Lisa M. Rimsza et al.
LEUKEMIA & LYMPHOMA (2007)
Bruton's tyrosine kinase and phospholipase C gamma 2 mediate chemokine-controlled B cell migration and homing
David J. J. de Gorter et al.
IMMUNITY (2007)
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients
Maher K. Gandhi et al.
BLOOD (2006)
Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival
Robin A. Roberts et al.
BLOOD (2006)
Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege
Takashi Ishida et al.
CANCER RESEARCH (2006)
Roles for phosphoinositide 3-kinases, Bruton's tyrosine kinase, and Jun kinases in B lymphocyte chemotaxis and homing
Saida Ortolano et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Mantle cell lymphomas acquire increased expression of CCL4, CCL5 and 4-1BB-L implicated in cell survival
S Ek et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions
LM Rimsza et al.
BLOOD (2006)
Prostaglandin E2 impairs CD4+ T cell activation by inhibition of Ick.: Implications in Hodgkin's lymphoma
JM Chemnitz et al.
CANCER RESEARCH (2006)
Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication
T Wündisch et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine
M Beyer et al.
BLOOD (2005)
Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α
M Nishio et al.
BLOOD (2005)
Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells
G Görgün et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival
S Deaglio et al.
BLOOD (2005)
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
S Monti et al.
BLOOD (2005)
The role of interleukin-3 in classical Hodgkin's disease
D Aldinucci et al.
LEUKEMIA & LYMPHOMA (2005)
Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells
T Alvaro et al.
CLINICAL CANCER RESEARCH (2005)
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma
NA Marshall et al.
BLOOD (2004)
Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas
L Trentin et al.
BLOOD (2004)
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
LM Rimsza et al.
BLOOD (2004)
Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites
B Streubel et al.
LEUKEMIA (2004)
The B cell antigen receptor controls integrin activity through Btk and PLCγ2
M Spaargaren et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Expression of CCL5/rantes by Hodgkin and reed-sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue
M Fischer et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
TJ Curiel et al.
NATURE MEDICINE (2003)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
The role of cytokines in classical Hodgkin lymphoma
BF Skinnider et al.
BLOOD (2002)
Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma
DL Zhu et al.
BLOOD (2002)
Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia
L Granziero et al.
BLOOD (2001)
Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma:: a multiparameter flow cytometry study
Y Xu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
CD4+T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome
SM Ansell et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Interleukin 4 therapy for patients with chronic lymphocytic leukaemia: a phase I/II study
J Lundin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
